LATEST ALERTS
Epidiolex for Europe may come from UK-grown cannabis
3rd December 2018 - News analysis |
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Health and science
Tests find labels on oil mis-state THC levels – sometimes dangerously
29th November 2018 - News analysis |
Most European CBD oils label their CBD content correctly but comparatively few are accurate about THC, a study in the Czech Republic has found
US federal government soliciting information for CBD research
22nd November 2018 - News analysis |
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
CBD treatments on the way as FDA grants 20th ‘orphan drug’ designation
14th November 2018 - News analysis |
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
CBD treatments ‘should be available on US health insurance’
5th November 2018 - News analysis |
Dr Sanjay Gupta, president of the American Pain Association (APA), has called on US insurance companies to cover CBD treatments for patients
Don’t judge cannabis by THC/CBD content alone, say scientists
1st November 2018 - News analysis |
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Restricted but in demand: France regulatory snapshot
23rd October 2018 - Regulatory reports |
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
FDA will pass on comments about CBD to WHO drug dependency experts
22nd October 2018 - News analysis |
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO)
A new Brazilian president is unlikely to free CBD from its legal chains
17th October 2018 - News analysis |
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
CBD prescriptions may be just around the corner for UK patients
16th October 2018 - News analysis |
CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis
Epilepsy research charity warns against unlicensed CBD products
12th September 2018 - News analysis |
A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence
‘Cannabis with nicotine affects brain differently than either on its own’
11th September 2018 - News analysis |
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco
Experiments on mice suggest you can’t get addicted to CBD
23rd August 2018 - News analysis |
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities
French warnings over ‘stores likely to be selling illegal products’
17th August 2018 - News analysis |
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation
Potentially deadly rat poison found in synthetic cannabinoids, says FDA
30th July 2018 - News analysis |
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says
US authorities call into question the legality of CBD
8th June 2018 - News analysis |
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness
CBD ‘may reduce temptation’ for quitters to pick up a cigarette
21st May 2018 - News analysis |
Cannabidiol (CBD) could be helpful in smoking cessation, but the area is little researched and more work is required, says a London scientist who will soon publish a paper on the topic
CBD in Europe: an overview of an emerging vaping market
24th April 2018 - Market reports |
Vaping is reported to be one of the best ways to absorb CBD, a cannabinoid present in cannabis which has relaxing and pain-relieving effects but produces no psychoactive “high”. E-liquid containing CBD is already on the market
French firm aims to roll out its nicotine dosage device in Europe and US
2nd October 2017 - News analysis |
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
